Authors
Latest:
Personalized Prevention: Identifying At-Risk Patients With Image-Based ScreeningAnna Sophie Mueller, MD discusses how imaging could advance risk identification in cardiovascular care.
Latest:
The Not So New Role of Pharmacists: No Longer an Overlooked Health Care ProviderPharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
Latest:
Reconciling Medications in Mental Health Assessments Protects PatientsProcess helps prevent errors for individuals with chronic disorders who often have a higher risk of drug-drug interactions.
Latest:
AACR Precision Medicine 2025: AACR Past-President Elaine R. Mardis, PhD, Discusses Highlights of the Meeting for PharmacistsConference Co-Chair and American Association for Cancer Research (AACR) Past President Elaine R. Mardis, PhD, explains that the conference provides pharmacy professionals with insights into the application of large-scale cancer genomics studies to real-world therapeutic responses.
Latest:
Insecticide Misuse With Cannabinoids and Its Resulting Complications: A Case ReportThe use of adulterated cannabinoids mixed with insecticides is becoming more common.
Latest:
Treatment-Free Remission in Chronic Myeloid LeukemiaTargeted therapies have greatly improved patient outcomes over the past 20 years.
Latest:
A Review of Anti-HER2 Targeted Agents in Non-Breast Solid TumorsThis review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.
Latest:
PrEP Prescribing Patterns Reveal Disparities in HIV Prevention Across SettingsThe study findings signal the need for improved equality in PrEP prescribing across various institutions and settings.
Latest:
New Drugs, New Decisions: How Pharmacists Are Guiding the Future of Hematologic CareVictoria Nacher, PharmD, BCOP, offers key insights about the evolving treatment landscape for hematologic malignancies.
Latest:
Implementing Pharmacist Advocacy Initiatives: A Step-by-Step Review Based on ExperienceThe process of supporting a cause for our profession can be highly rewarding. As pharmacists, we must take charge to enact change.
Latest:
Artificial Intelligence Tools Can Help Foster Leadership in PharmacyLeaders Must Continue to Prioritize Empathy and Human Connection.
Latest:
Leveraging Social Media for Success: Insights From Pharmaceutical Postdoctoral FellowsPractical strategies for pharmacy professionals to build a social media presence, expand their network, and advance their careers in the evolving digital landscape.
Latest:
The Not So New Role of Pharmacists: No Longer an Overlooked Health Care ProviderPharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
Latest:
Clinical Overview: Cardiovascular Implantable Electronic DevicesPharmacists need to ensure anticoagulants are held appropriately before and after surgery to prevent complications from for CIED infections.
Latest:
Emerging Bispecific T-Cell Engagers in Myeloma: Promises and HurdlesThe multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.
Latest:
Removal of Phenylephrine From Nasal Decongestants Could Reshape OTC Cold RemediesIntranasal decongestants are preferred alternatives to oral phenylephrine for relief of nasal congestion.
Latest:
Finerenone and the Future of Diabetes-Related Kidney CareFinerenone emerges as a promising treatment for patients with diabetes and chronic kidney disease, significantly reducing cardiovascular and renal risks.
Latest:
ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient SafetyReady-to-use glucagon simplifies hypoglycemia rescue by providing easy-to-use options for patients and caregivers.
Latest:
Recognize the Value of Health Care VolunteersThe health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
Latest:
Access to C. difficile Treatments Presents Challenges During Transitions of CareThis inflammation of the colon poses a substantial burden to patients and the health care system.
Latest:
From Hesitation to Vaccination: Tackling Vaccine HesitancyPatient fears can be mitigated by pharmacists who use targeted communication strategies to bolster acceptance.
Latest:
Pharmacists Have a Significant Role in the Prevention of Travel-Related DiseasesWhen helping individuals prepare for travel, pharmacists must make travel health recommendations and know common travel-related immunizations and additional resources.
Latest:
The Role of Pharmacists in HIV Care Continues to ExpandPharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.
Latest:
Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology PharmacyStaying current across every disease state, drug, and toxicity is burning people out.
Latest:
New Walgreens Program Aims to Enable Pharmacy Technicians to Pursue PharmD DegreesPharmStart empowers pharmacy technicians to pursue their education with tuition-free prerequisites, addressing barriers to entering pharmacy school.
Latest:
Future Considerations for the Management of HyperlipidemiaPanelists discuss how anticipated updates to cholesterol guidelines and related cardiovascular-kidney-metabolic health (CKM) guidelines this year are expected to shape low-density lipoprotein cholesterol (LDL-C) management strategies and influence treatment recommendations for high-risk patients.
Latest:
A Brief Overview of Loop Diuretics Used in Heart FailureThe combination of loop diuretics with other drugs that act at different pharmacologic targets has been shown to improve diuretic response in patients with heart failure.
Latest:
Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical ConsiderationsThis article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
